GARDASIL: Parece no ser cosa para varones...

Harvard University researchers have found that public health authorities would do better to extend the vaccination of adolescent girls against human papillomavirus (HPV) than to launch a campaign to get boys and young men vaccinated as well. The study, published in the British Medical Journal, comes as the Food and Drug Administration considers a proposal from Merck, the makers of the HPV vaccine Gardasil, to approve the vaccine for boys between the ages of nine and 15. (Más...)

By Julie Steenhuysen CHICAGO, Oct 8
Vaccinating boys against the virus that causes cervical cancer and genital warts does not appear to be cost-effective, U.S. researchers said on Thursday.

Assuming all girls get the shot, adding boys to a national vaccination program may not be worth the expense, they said. (Más)